Last reviewed · How we verify

NCT05962619

Arthrocentesis Alone Versus Arthrocentesis With Hyaluronic Acid Injection

Status unknown NA Last updated 27 July 2023
What this trial tests

NA trial testing arthrocentesis alone in Temporomandibular Joint Dysfunction Syndrome in 42 participants. Status unknown.

Timeline
1 August 2023
Primary endpoint
1 August 2024
2 August 2024

Quick facts

Lead sponsorAssiut University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposetreatment
Enrollment42
Start date1 August 2023
Primary completion1 August 2024
Estimated completion2 August 2024

Drugs / interventions tested

Conditions studied

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Temporomandibular Joint Dysfunction Syndrome or Arthrocenteses. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparison between Arthrocentesis alone arthrocentesis with hyaluronic acid injection in management of temporomandibular joint dysfunction in the form of anterior disc displacement with reduction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Temporomandibular Joint Dysfunction Syndrome

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05962619.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing